Open AccessCarvedilol may attenuate liver cirrhosis by inhibiting angiogenesis through the VEGF-Src-ERK signaling pathway
Author(s) -
Qian Ding
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i32.9566
Subject(s) - carvedilol , angiogenesis , mapk/erk pathway , proto oncogene tyrosine protein kinase src , pharmacology , vascular endothelial growth factor , signal transduction , chemistry , kinase , cell growth , microbiology and biotechnology , endocrinology , medicine , cancer research , biology , biochemistry , heart failure , vegf receptors
To investigate the effect of carvedilol on angiogenesis and the underlying signaling pathways.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom